A three-part randomized, double-blind, placebo-controlle

  • Vehe, Richard K (PI)

Project: Research project

Project Details

Description

A three-part randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of secukinumab treatment in Juvenile Idiopathic arthritis subtypes of psoriatic and enthesitis-related arthritis
StatusActive
Effective start/end date1/1/1811/30/21

Funding

  • NOVARTIS PHARMACEUTICALS CORPORATION

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.